MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr | ₹-439 Cr | ₹-444 Cr |
What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2023 | ₹-1,054 Cr |
Mar2022 | ₹-1,369 Cr |
Mar2021 | ₹-1,222 Cr |
Mar2020 | ₹-439 Cr |
Mar2019 | ₹-444 Cr |
How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-1,054 Cr | Negative | |
Mar2022 | ₹-1,369 Cr | Negative | |
Mar2021 | ₹-1,222 Cr | Negative | |
Mar2020 | ₹-439 Cr | Negative | |
Mar2019 | ₹-444 Cr | - |
Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹82,661.8 Cr | -2.3% | -14% | 57.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -2.3% |
-14% |
57.7% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses